These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 80349)

  • 1. [Changes in laboratory tests after treatment with a new contraceptive agent].
    Cervantes LF; López Barcena J; Calderón Márquez JJ
    Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.
    Tankeyoon M; Dusitsin N; Poshyachinda V; Larsson-Cohn U
    Contraception; 1976 Aug; 14(2):199-214. PubMed ID: 949896
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose and insulin levels during treatment with a combined oral contraceptive agent.
    Larsson-Cohn U
    Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Rubio-Lotvin B; Gonzales-Ansorena R
    Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E; Lachnit U; Gaude R; Schillinger E
    Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
    Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
    Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal cytology in oral contraceptive.
    Pande K; Banait S
    J Obstet Gynaecol India; 1975 Dec; 25(6):819-22. PubMed ID: 1228038
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical observations with Rigevidon.
    Bálint S
    Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in carbohydrate metabolism brought about by combined oral contraceptives].
    De Oliveira MH; De Oliveira CF
    Gynecologie; 1978; 29(4):403-7. PubMed ID: 720724
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
    Petersen KR; Skouby SO; Dreisler A; Kühl C
    Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology and oral contraception.
    Briggs MH; Briggs M
    N Z Med J; 1976 Apr; 83(562):257-61. PubMed ID: 183175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilest--a combined OC.
    Drug Ther Bull; 1991 Dec; 29(26):103-4. PubMed ID: 1790761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.